Ascent Biomedical Ventures
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
3Deep-tech portfolio0 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
44Co-investorsShare a portfolio company
Portfolio · 3 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Vor Biopharma | Biotech | Public | Jul 10, 2020 | $110.1M |
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
Peer ranks
Portfolio size#136
Portfolio exits#69
Raises, 12 months#88
Co-investors#39
Co-investors
- Perceptive AdvisorsVenture capital3 shared
- Third Rock VenturesVenture capital3 shared
- Boxer CapitalVenture capital2 shared
- Deerfield Capital ManagementVenture capital2 shared
- Gurnet Point CapitalVenture capital2 shared
- GVVenture capital2 shared
- Perceptive Life SciencesVenture capital2 shared
- Alexandria Venture InvestmentsVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- Astellas Venture ManagementVenture capital1 shared
Sectors
- Biotech3
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.